Market Overview:
The global cell-free protein expression system market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for recombinant proteins and rising investments in R&D by pharmaceutical and biotechnology companies. The global cell-free protein expression system market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into E. coli system, rabbit reticulocytes system, wheat germ system, insect cells system, mammalian cells systems (CHO cells), and others. The E. coli systems segment dominates the global cell-free protein expression systems market due to its low cost and high efficiency as compared to other types of systems available in the market. Pharmaceutical companies are increasingly adopting recombinant proteins for drug discovery and development owingto their therapeutic potentialand specificityfor certain diseases conditions over traditional small molecules drugs therapy .
Product Definition:
A cell-free protein expression system is a biochemical assay in which the desired protein is expressed without using cells.
1) Increased throughput - since there is no need to grow cells, large numbers of proteins can be screened in parallel.
2) Reduced costs - since there is no need for expensive equipment or media, this method can be used to screen large numbers of proteins at low cost.
3) Increased flexibility - many different types of proteins can be expressed in a cell-free system, including difficult-to-express proteins such as membrane proteins and multi-domain proteins.
E.Coli System:
Escherichia coli (E.coli) is a gram-negative bacteria belonging to the Enterobacteriaceae family. E.coli possesses a single circular chromosome of 1,816 nucleotides length which replicates continuously and can grow in the presence as well as absence of nutrients. The E.
Rabbit Reticulocytes System:
Rabbit reticulocytes system is used for the isolation of high-quality cell-free protein. It works on the principle that positive cells in a blood sample bind to negatively charged beads and negative cells do not bind to positively charged beads. The bound proteins are then isolated with an antibody coupled with an antigen, which is usually done using rabbit antibodies specific for chicken egg ovalbumin (CEV).
Application Insights:
The academic research segment dominated the global market in terms of revenue share in 2017. The growth is attributed to rising number of R&D activities for production of biopharmaceuticals using cell-free protein expression systems. For instance, a research study published by researchers from China and Germany reported about development of a mammalian cell-free protein expression system that can be used for efficient production of monoclonal antibodies. This system can also be utilized for producing other therapeutic proteins with higher yield and purity than conventional methods.
The pharmaceutical application segment is expected to witness lucrative CAGR over the forecast period owing to increasing adoption across drug discovery programs as well as clinical trials stages I & II clinical studies involving recombinant proteins produced via proteomics & genomics techniques respectively.
Regional Analysis:
North America accounted for the largest revenue share in 2017. The presence of a large number of biotechnology companies involved in protein expression technology and high investment by government organizations are some factors contributing to its largest market share. Furthermore, increasing demand for medicines that are free from animal-based proteins is expected to drive the regional market over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising investments by governments and private firms in emerging economies such as China, India, Singapore, and South Korea. In addition, growing awareness regarding cell-free protein technology among researchers has led to an increase in applications across various industries resulting into increased demand for CELLFEEDS™ systems used across this region.
Growth Factors:
- Increasing demand for cell-free protein expression system owing to its advantages over traditional methods.
- Growing research and development activities in the field of biotechnology and life sciences.
- Rising number of biotechnology and pharmaceutical companies investing in cell-free protein expression systems for drug discovery and development processes.
- Technological advancements in cell-free protein expression systems that are helping researchers to achieve better yields and quality proteins.
Scope Of The Report
Report Attributes
Report Details
Report Title
Cell-Free Protein Expression System Market Research Report
By Type
E.Coli System, Rabbit Reticulocytes System, Wheat Germ System, Insect Cells System, Mammalian System, Others
By Application
Pharmaceutical, Academic Research
By Companies
Thermo Fisher Scientific, Promega, Takara Bio, New England Biolabs, Creative Biolabs, CellFree Sciences, Synthelis, Arbor Bioscience, Cube Biotech, Cambridge Isotope Laboratories, Profacgen, Bioneer, GeneCopoeia
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
197
Number of Tables & Figures
138
Customization Available
Yes, the report can be customized as per your need.
Global Cell-Free Protein Expression System Market Report Segments:
The global Cell-Free Protein Expression System market is segmented on the basis of:
Types
E.Coli System, Rabbit Reticulocytes System, Wheat Germ System, Insect Cells System, Mammalian System, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pharmaceutical, Academic Research
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Thermo Fisher Scientific
- Promega
- Takara Bio
- New England Biolabs
- Creative Biolabs
- CellFree Sciences
- Synthelis
- Arbor Bioscience
- Cube Biotech
- Cambridge Isotope Laboratories
- Profacgen
- Bioneer
- GeneCopoeia
Highlights of The Cell-Free Protein Expression System Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- E.Coli System
- Rabbit Reticulocytes System
- Wheat Germ System
- Insect Cells System
- Mammalian System
- Others
- By Application:
- Pharmaceutical
- Academic Research
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cell-Free Protein Expression System Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Cell-free protein expression system is a technology that allows the production of proteins in vitro without using cells. The system uses recombinant DNA technology to produce proteins from gene sequences.
Some of the major companies in the cell-free protein expression system market are Thermo Fisher Scientific, Promega, Takara Bio, New England Biolabs, Creative Biolabs, CellFree Sciences, Synthelis, Arbor Bioscience, Cube Biotech, Cambridge Isotope Laboratories, Profacgen, Bioneer, GeneCopoeia.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cell-Free Protein Expression System Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Cell-Free Protein Expression System Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Cell-Free Protein Expression System Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Cell-Free Protein Expression System Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Cell-Free Protein Expression System Market Size & Forecast, 2020-2028
4.5.1 Cell-Free Protein Expression System Market Size and Y-o-Y Growth
4.5.2 Cell-Free Protein Expression System Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 E.Coli System
5.2.2 Rabbit Reticulocytes System
5.2.3 Wheat Germ System
5.2.4 Insect Cells System
5.2.5 Mammalian System
5.2.6 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Pharmaceutical
6.2.2 Academic Research
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cell-Free Protein Expression System Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cell-Free Protein Expression System Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 E.Coli System
9.6.2 Rabbit Reticulocytes System
9.6.3 Wheat Germ System
9.6.4 Insect Cells System
9.6.5 Mammalian System
9.6.6 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Pharmaceutical
9.10.2 Academic Research
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 E.Coli System
10.6.2 Rabbit Reticulocytes System
10.6.3 Wheat Germ System
10.6.4 Insect Cells System
10.6.5 Mammalian System
10.6.6 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Pharmaceutical
10.10.2 Academic Research
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 E.Coli System
11.6.2 Rabbit Reticulocytes System
11.6.3 Wheat Germ System
11.6.4 Insect Cells System
11.6.5 Mammalian System
11.6.6 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Pharmaceutical
11.10.2 Academic Research
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 E.Coli System
12.6.2 Rabbit Reticulocytes System
12.6.3 Wheat Germ System
12.6.4 Insect Cells System
12.6.5 Mammalian System
12.6.6 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Pharmaceutical
12.10.2 Academic Research
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 E.Coli System
13.6.2 Rabbit Reticulocytes System
13.6.3 Wheat Germ System
13.6.4 Insect Cells System
13.6.5 Mammalian System
13.6.6 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Pharmaceutical
13.10.2 Academic Research
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cell-Free Protein Expression System Market: Competitive Dashboard
14.2 Global Cell-Free Protein Expression System Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Thermo Fisher Scientific
14.3.2 Promega
14.3.3 Takara Bio
14.3.4 New England Biolabs
14.3.5 Creative Biolabs
14.3.6 CellFree Sciences
14.3.7 Synthelis
14.3.8 Arbor Bioscience
14.3.9 Cube Biotech
14.3.10 Cambridge Isotope Laboratories
14.3.11 Profacgen
14.3.12 Bioneer
14.3.13 GeneCopoeia
